Ketamine Hydrochloride Injection Supply

The contract involves the supply of Ketamine Hydrochloride Injection identified by NSN 6505013391909, meeting stringent regulatory requirements including FDA current Good Manufacturing Practices, USP standards, and specific military packaging guidelines. The product must ensure sterility throughout its lifecycle, maintain full batch traceability, and adhere to precise labeling protocols to support operational readiness and compliance with defense medical protocols. Delivery is required within the domestic United States, with all units produced and shipped under these strict quality and documentation controls to ensure immediate usability in military medical environments. The contract is classified as a subcontract under the NAICS code 325412 for pharmaceutical preparation manufacturing and is administered by the Defense Logistics Agency on behalf of the Department of Defense. The solicitation was posted on July 18, 2026, and is associated with the contract line SPE2DX25D8022, with delivery details tied to SPE2D926F7430. The performance location and point of contact details are not specified, indicating centralized oversight with decentralized execution through qualified suppliers. This procurement supports critical military medical needs and demands full compliance with federal and defense-specific pharmaceutical standards without exception.